{"id":"W4410811460","doi":"10.1200/jco.2025.43.16_suppl.5066","title":"Canadian Cancer Trials Group (CCTG) IND.234/223: PC_BETS (Prostate Cancer Biomarker Enrichment and Treatment Selection)–A molecularly selected cooperative group platform study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Cancer Care Ontario; Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Toronto; Western University; Centre Hospitalier de l’Université de Montréal; McGill University; Juravinski Cancer Centre; Jewish General Hospital; London Health Sciences Centre; McMaster University; University Health Network; Ottawa Hospital; BC Cancer Agency","funders":"F. Hoffmann-La Roche; Pfizer","keywords":"Prostate cancer; Medicine; Cancer; Biomarker; Oncology; Internal medicine; Genetics; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001925518,0.0007774149,0.0009451178,0.0002598619,0.0007021193,0.0006782063,0.0006957315,0.001119938,0.01522821],"category_scores_gemma":[0.00139294,0.0003211688,0.0007328846,0.001045873,0.0004665827,0.0003042969,0.0004826194,0.001156128,0.002166331],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002159374,"about_ca_system_score_gemma":0.008615552,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04523345,"about_ca_topic_score_gemma":0.1488248,"domain_scores_codex":[0.9993382,0.000330058,0.00002377369,0.00007572475,0.0001336382,0.00009844134],"domain_scores_gemma":[0.9992841,0.00008675606,0.0001225262,0.0000649942,0.0001113765,0.0003302073],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5389321,0.005869522,0.01875764,0.002737962,0.002106716,0.0002696118,0.0002097117,0.00182518,0.00800497,0.002606049,0.2541288,0.1645516],"study_design_scores_gemma":[0.6598616,0.04523015,0.09831371,0.0005486879,0.002329228,0.0002678941,0.00008957212,0.001362792,0.001323433,0.001778999,0.18882,0.00007386716],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5913876,0.0209057,0.004202477,0.01666034,0.001669377,0.06542891,0.173708,0.0008734632,0.1251642],"genre_scores_gemma":[0.7643583,0.00988772,0.01459213,0.01212937,0.001361091,0.05671601,0.07775927,0.0003008316,0.06289519],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04523345,"threshold_uncertainty_score":0.08994037,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1594768418501787,"score_gpt":0.5089278038883972,"score_spread":0.3494509620382185,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}